Recent Articles

August 29, 2016 8:30 am
Tim Moran, Director of Life Science Research Product Management, Dassault Systèmes BIOVIA
Addressing challenges surrounding bispecific antibodies and antibody drug conjugates.
August 23, 2016 8:30 am
Matthew Cutler, Principal, St. Louis Metro Office, Harness Dickey & Pierce, PLC
Companies producing generics are using IPR to knock out key patents to expand into new markets.
August 19, 2016 8:30 am
Reinhold van Ackeren, Head of Marketing & Product Management, METTLER TOLEDO
Tackling print inspection challenges.
August 18, 2016 8:30 am
Meg LaTorre-Snyder
How single-use systems became standardized.
August 17, 2016 8:30 am
Steven Kelliher, Senior Sales Representative, Emerson Process Management
Wireless instrumentation is proving its worth and overcoming objections in the heavily regulated and often conservative pharmaceutical industry.
Ravi Shankar, Life Sciences Industry Manager, Endress+Hauser
Life sciences companies must perform regular calibrations of instrumentation to meet regulations, but these can be costly. Modern instrumentation simplifies the process.
Meg LaTorre-Snyder
Despite a government-mandated, multi-year timeline for implementation, many industry experts are left questioning how to achieve and sustain unit-level traceability.
Anshul Thakral, General Manager of Life Sciences, GLG
The four factors influencing the migration toward on-demand talent in the pharmaceutical industry.
Meg LaTorre-Snyder
Since the world-changing vote on June 23rd, countless questions have arisen as to the referendum's impact on the UK going forward—as well as what this means for the pharmaceutical and biopharmaceutical industries.
Ricardo Alonso-Zaldivar, Associated Press
A safeguard for Medicare beneficiaries has become a way for drugmakers to get paid billions of dollars for pricey medications at taxpayer expense, government numbers show.
Subscribe to Pharmaceutical Processing